The evolving role of liver biopsy in non-alcoholic fatty liver disease

Evaluation patients with nonalcoholic steatohepatitis (NASH) imply the need of appropriate assessment of disease severity (i.e. the presence of NASH) as well as of the disease stage (i.e. the extent of liver fibrosis). Liver biopsy (LB) is still considered the gold standard for diagnosing NASH as we...

Full description

Bibliographic Details
Main Authors: Juan Pablo Arab, Francisco Barrera, Marco Arrese
Format: Article
Language:English
Published: Elsevier 2018-11-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119310506